PT - JOURNAL ARTICLE AU - Shunxiang Huang AU - Lin Wu AU - Li Xu AU - Aihong Zhang AU - Li Sheng AU - Feng Liu AU - Long Zhou AU - Jing Li AU - Rongzhang Hao AU - Hua Qian AU - Sheng Fang AU - Zhongyi Wang AU - Yingru Li AU - Yuguo Li AU - Chan Lu AU - Qihong Deng TI - Transmission Dynamics of Coronavirus Disease 2019 (COVID-19) in the World: The Roles of Intervention and Seasonality AID - 10.1101/2020.07.17.20156430 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.17.20156430 4099 - http://medrxiv.org/content/early/2020/07/19/2020.07.17.20156430.short 4100 - http://medrxiv.org/content/early/2020/07/19/2020.07.17.20156430.full AB - The coronavirus disease 2019 (COVID-19) is spreading rapidly all over the world. The transmission dynamics of the COVID-19 pandemic is still unclear, but developing strategies for mitigating the severity of the pandemic is yet a top priority for global public health. In this study, we developed a novel compartmental model, SEIR-CV(susceptible-exposed-infectious-removed with control variables), which not only considers the key characteristics of asymptomatic infection and the effects of seasonal variations, but also incorporates different control measures for multiple transmission routes, so as to accurately predict and effectively control the spread of COVID-19. Based on SEIR-CV, we predicted the COVID-19 epidemic situation in China out of Hubei province and proposed corresponding control strategies. The results showed that the prediction results are highly consistent with the outbreak surveillance data, which proved that the proposed control strategies have achieved sound consequent in the actual epidemic control. Subsequently, we have conducted a rolling prediction for the United States, Brazil, India, five European countries (the United Kingdom, Italy, Spain, Germany, and France), southern hemisphere, northern hemisphere, and the world out of China. The results indicate that control measures and seasonal variations have a great impact on the progress of the COVID-19 pandemic. Our prediction results show that the COVID-19 pandemic is developing more rapidly due to the impact of the cold season in the southern hemisphere countries such as Brazil. While the development of the pandemic should have gradually weakened in the northern hemisphere countries with the arrival of the warm season, instead of still developing rapidly due to the relative loose control measures such as the United States and India. Furthermore, the prediction results illustrate that if keeping the current control measures in the main COVID-19 epidemic countries, the pandemic will not be contained and the situation may eventually turn to group immunization, which would lead to the extremely severe disaster of about 5 billion infections and 300 million deaths globally. However, if China’s super stringent control measures were implemented from 15 July, 15 August or 15 September 2020, the total infections would be contained about 15 million, 32 million or 370 million respectively, which indicates that the stringent and timely control measures is critical, and the best window period is before September for eventually overcoming COVID-19.Significance COVID-19 is now posing a huge threat to global public health. The key features such as asymptomatic infection and droplet or airborne transmission make COVID-19 more easily spread and more widely distributed around the world. It is an urgent need to explore the optimal intervention strategies and measures to contain the pandemic. Our novel SEIR-CV compartmental model considers the new features of COVID-19, exhibits the impact of the intervention strategies and seasonal variations, and thus can accurately predicts its trajectory in China and the rest of the world. Our research results suggest that control measures and seasonal variations have a great impact on the development of the COVID-19 pandemic, which can only be contained by stringent strategies during the best window period before September 2020 for eventually overcoming COVID-19, otherwise it would cause a severer global catastrophe.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the National Key Research and Development Program of China (2016YFC0209000) and the National Natural Science Foundation of China (41375154, 21777193, 41875181, and 41977369).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:XiangYa School of Public Health, Central South UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://www.who.int/ http://qianxi.baidu.com/